- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02593240
Worksite Wellness Randomized Controlled Trial
August 24, 2020 updated by: Sai Krupa Das, Tufts University
Worksite Wellness Study
Worksites offer attractive locations for reducing the national prevalence of overweight and obesity.
Interventions that are both effective and sustainable for producing long-term changes in health and employee wellness are urgently needed.
In an 18-month worksite randomized controlled trial in 12 worksites, this study will test two lifestyle approaches designed to facilitate behavior modification for achieving long-term improvements in health and quality of life.
Worksites randomized to the immediate intervention arm will receive the two on-site wellness programs and the randomized control sites will participate in outcomes assessments for the initial 6-month period, after which participants will receive vouchers to participate in the program of their choice.
The primary focus of the worksite wellness study is to identify ways to improve health-related quality of life, with a particular focus on a decrease in cardiometabolic risk factors, including weight, improved weight-related wellness, and improved energy level in work and life.
The two interventions will be separately tested against the control condition in intention-to-treat models and with a completers analysis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
554
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Tufts University Human Nutrition Research Center on Aging
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Willingness to sign an informed consent form
- Willingness to provide release from his/her physician before starting the intervention program-a requirement for each of the 3 wellness programs
- Willingness to provide email identification (ID) and contact information to the commercial program facilitators to receive program materials and other feedback related to program progress
- Willingness to complete outcome assessments and self-monitoring in order to track intervention effectiveness
- BMI ≥ 20 kg/m2 and < 50 kg/m2 at screening, if participant opts into the HPI arm
- BMI ≥ 25 kg/m2 and < 50 kg/m2 at screening, if participant opts into the weight loss arm
Exclusion Criteria:
- Employees who are temporary contract workers or employees who work remotely most of the time
- < 21 years of age
- Participation in a weight loss program or intensive wellbeing program at time of enrollment
- Pregnant or lactating (per self-reports, now or intended during study)
- Prior weight loss surgery or a medical complication that would prevent full participation
- Multiple severe dietary intolerances (e.g. gluten combined with dairy or meat) which would reduce intervention adherence
- Non-English speaking
- Individuals who have lost > 15 pounds in the past 6 months
- Mobility limitations (inhibiting the ability to stand on one's own or get on and off of the scale)
- Major diseases including active cancer or cardiovascular disease
- BMI < 25 kg/m2 or ≥ 50 kg/m2 at screening, for those that opt-in to the weight-loss group
BMI <20 kg/m2 or ≥ 50 kg/m2 at screening, for those that opt-in to the HPI group
For those interested in the weight loss intervention, additional exclusion criteria are as follows:
- Any condition that influences the ability to absorb food (e.g. inflammatory bowel disease or celiac disease)
- Very active individuals (> 2 hours/day or >14 hours/week of vigorous activity).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Human Performance Institute©
These participants will be part of the intervention sites and will receive the Human Performance Institute© intervention for the duration of the study (18 months).
|
The Human Performance Institute© (HPI) training workshop is a comprehensive individual development training program that focuses on the concept of energy management.
The primary aim of this program is to help individuals develop attitudes, habits, and behaviors that increase their levels of daily energy, life satisfaction, and overall functioning.
The course is delivered at an off-site location over 2.5 days, by 3 coaches, in a group format of 25 - 32 participants (with employees from more than one worksite per group).
|
|
EXPERIMENTAL: The iDiet® with Voucher
These participants will be part of the intervention sites and will receive the iDiet® with Voucher for the duration of the study (18 months).
|
The intensive iDiet® group behavioral weight loss program delivered in person at the worksite or by videoconference and with support of the program's web platform.
This intervention will be delivered by trained group leaders and will initially include weekly 1-hour support and education meetings of 20 participants/group with a message board for group communication and individual communication with the group leader.
Over time support will be provided online rather than in live meetings.
The intervention involves a weight loss behavioral program with particular emphasis on hunger reduction and craving control for both weight loss and prevention of weight regain.
Half of the participants per worksite receiving the Diet® intervention will be randomized to receive gift cards monthly for the first 6 months to purchase foods at their local grocery store (partial costs).
|
|
EXPERIMENTAL: The iDiet® with Food
These participants will be part of the intervention sites and will receive the iDiet® with Food for the duration of the study (18 months).
|
The intensive iDiet® group behavioral weight loss program will be delivered in person at the worksite or by videoconference and with support of the program's web platform.
This intervention will be delivered by trained group leaders and will initially include weekly 1-hour support and education meetings of 20 participants/group with a message board for group communication and individual communication with the group leader.
Over time support will be provided online rather than in live meetings.
The intervention involves a weight loss behavioral program with particular emphasis on hunger reduction and craving control for both weight loss and prevention of weight regain.
Half of the participants per worksite receiving the iDiet® intervention will be randomized to receive commercial dried food products (partial supply) from Yevo Intl., which are designed to help with weight control and health.
|
|
NO_INTERVENTION: Wait-listed control
These participants will be part of the control sites and will participate in outcome assessments for a 6-month period only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight (iDiet/Healthy Weight for Living arms)
Time Frame: 1.5 years
|
Fasted measurements of weight obtained in duplicate to ±0.1 kg at baseline, 6, 12, and 18 months using the TANITA TBF-300A.
|
1.5 years
|
|
Quality of Life (HPI arm)
Time Frame: 1.5 years
|
Assessed by the RAND Short Form 36 Health Survey (SF-36) at baseline, 6, 12, and 18 months.
|
1.5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure
Time Frame: 1.5 years
|
Systolic and diastolic blood pressure (mm Hg) measured to the nearest 1 mm Hg at baseline, 6, 12, and 18 months using a validated automated monitor (3 fasted measurements, 5 minutes apart, after 5 minutes of quiet sitting).
|
1.5 years
|
|
Cholesterol
Time Frame: 1.5 years
|
Total cholesterol, high-density lipoprotein, and low-density lipoprotein measured at baseline, 6, 12, and 18 months using the Alere Cholestech LDX® System, which requires 40 microliters of blood (fasted lipid panel).
|
1.5 years
|
|
Triglycerides
Time Frame: 1.5 years
|
Triglycerides measured at baseline, 6, 12, and 18 months using the Alere Cholestech LDX® System (fasted lipid panel).
|
1.5 years
|
|
Glucose
Time Frame: 1.5 years
|
Fasting blood glucose measured at baseline, 6, 12, and 18 months using the Alere Cholestech LDX® System.
|
1.5 years
|
|
Hemoglobin A1c
Time Frame: 1.5 years
|
HbA1c measured at baseline, 6, 12, and 18 months using the Siemens DCA Vantage, which requires 1 microliter of blood (fasted measurement).
|
1.5 years
|
|
Eating behavior (Food Preferences)
Time Frame: 1.5 years
|
Assessed by the Food Preferences Questionnaire (self-administered) at baseline, 6, 12, and 18 months.
|
1.5 years
|
|
Eating behavior (Three-Factor Eating)
Time Frame: 1.5 years
|
Assessed by the Three-Factor Eating Questionnaire (self-administered) at baseline, 6, 12, and 18 months.
|
1.5 years
|
|
Eating behavior (Food Cravings)
Time Frame: 1.5 years
|
Assessed by the Food Cravings Questionnaire - Trait (self-administered) at baseline, 6, 12, and 18 months.
|
1.5 years
|
|
Depression
Time Frame: 1.5 years
|
Assessed by the Center for Epidemiological Studies Depression Scale (self-administered) at baseline, 6, 12, and 18 months.
|
1.5 years
|
|
Mood
Time Frame: 1.5 years
|
Assessed by the Profile of Mood States (self-administered) at baseline, 6, 12, and 18 months.
Variables include anger-hostility, depression-dejection, fatigue-inertia, and vigor-activity.
|
1.5 years
|
|
Physical Activity
Time Frame: 1.5 years
|
Assessed by the International Physical Activity Questionnaire (self-administered) at baseline, 6, 12, and 18 months.
|
1.5 years
|
|
Well-being
Time Frame: 1.5 years
|
Assessed by the Ryff Purpose in Life scale (self-administered) at baseline, 6, 12, and 18 months.
|
1.5 years
|
|
Productivity
Time Frame: 1.5 years
|
Assessed by the Work Productivity and Impairment scale (self-administered) at baseline, 6, 12, and 18 months.
|
1.5 years
|
|
Sleep
Time Frame: 1.5 years
|
Assessed by the Medical Outcomes Study Sleep Questionnaire (self-administered) at baseline, 6, 12, and 18 months.
|
1.5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2015
Primary Completion (ACTUAL)
March 1, 2018
Study Completion (ACTUAL)
March 1, 2018
Study Registration Dates
First Submitted
October 21, 2015
First Submitted That Met QC Criteria
October 29, 2015
First Posted (ESTIMATE)
November 1, 2015
Study Record Updates
Last Update Posted (ACTUAL)
August 27, 2020
Last Update Submitted That Met QC Criteria
August 24, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11768
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
Clinical Trials on Human Performance Institute©
-
Arash Asher, MDVoxxLifeCompletedNeuropathy | Chemotherapy-induced Peripheral Neuropathy | Neuropathy;PeripheralUnited States
-
GlaxoSmithKlineCompleted
-
University of ConnecticutUnited States Department of Defense; AMP Human; Park City, UTCompletedCognitive Change | Electrolyte and Fluid Balance Conditions | Fluid Retention | Heat Exposure | Fluid Loss | Hyperhydration | Sodium RetentionUnited States
-
University of ConnecticutUnited States Department of Defense; AMP Human; Park City, UTCompletedElectrolyte and Fluid Balance Conditions | Fluid Retention | Dehydration (Physiology) | Heat Stress | Renal Injury | Sodium RetentionUnited States
-
Medical University of WarsawHuman Biome Institute S.A.CompletedParkinson DiseasePoland
-
Medical University of WarsawMedical Research Agency, Poland; Human Biome Institute S.A.RecruitingAntimicrobial Drug Resistance | Drug Resistance, BacterialPoland
-
University of Colorado, DenverNational Cancer Institute (NCI)RecruitingPediatric Cancer | SurvivorshipUnited States
-
Mayo ClinicRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States